Method of lowering cholesterol
    72.
    发明授权
    Method of lowering cholesterol 失效
    降低胆固醇的方法

    公开(公告)号:US5574071A

    公开(公告)日:1996-11-12

    申请号:US468114

    申请日:1995-06-06

    摘要: A method of lowering cholesterol which comprises administering to a host requiring such treatment an effective amount of a compound of the formula ##STR1## wherein one of R.sup.1 and R.sup.2 is C.sub.1-7 -alkyl and the other is C.sub.1-7 -alkyl or C.sub.2-6 -alkenyl-methyl;L is C.sub.1-11 -alkylene or C.sub.2-11 -alkenylene optionally bonded to the phenyl group via an O atom or L is 1,4-phenylene;n is 0 or, when L contains an O atom, n is 0 or 1;Q is C.sub.1-7 -alkyl, C.sub.2-10 alkenyl or a group of formula ##STR2## wherein R is H, halogen, CF.sub.3, CN or NO.sub.2 ; R.sup.3 and R.sup.4 are H, C.sub.1-4 -alkyl or halogen; andR.sup.5 is H or, when R is H, R.sup.5 is H or halogen;or a pharmaceutically acceptable acid addition salt thereof, as well as certain compounds of formula I, are described.

    摘要翻译: 一种降低胆固醇的方法,其包括向需要这种治疗的宿主施用有效量的式I化合物,其中R 1和R 2之一是C 1-7 - 烷基,另一个是C 1-7 - 烷基或C 2 -C -6-链烯基 - 甲基; L是通过O原子任选地键合到苯基的C1-11亚烷基或C2-11亚烯基,或L是1,4-亚苯基; n为0或L为O原子时,n为0或1; Q是C 1-7 - 烷基,C 2-10烯基或式(III)基团,其中R是H,卤素,CF 3,CN或NO 2; R3和R4是H,C1-4烷基或卤素; R5为H或当R为H时,R5为H或卤素; 或其药学上可接受的酸加成盐,以及某些式I化合物。

    Pyrrolidine compounds
    77.
    发明授权
    Pyrrolidine compounds 失效
    吡咯烷化合物

    公开(公告)号:US06444829B1

    公开(公告)日:2002-09-03

    申请号:US09900350

    申请日:2001-07-06

    IPC分类号: C07D20748

    摘要: The present invention relates to a pyrrolidine compound and pharmaceutically acceptable esters and/or salts thereof. The compounds are useful as inhibitors of metalloproteases, e.g. zinc proteases, particularly zinc hydrolases, and which are effective in treating disease states are associated with vasoconstriction of increasing occurrences.

    摘要翻译: 本发明涉及吡咯烷化合物及其药学上可接受的酯和/或盐。 这些化合物可用作金属蛋白酶的抑制剂,例如。 锌蛋白酶,特别是锌水解酶,其在治疗疾病状态中有效,与增加事件的血管收缩相关。